Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | NGL | CQP |
|---|---|---|
| Price | $15.75 | $63.26 |
| Change today | ▼ 3.31% | ▲ 3.18% |
| Market cap | $1.97B | $30.62B |
| Return, 3 months | +2.1% | +0.6% |
| Return, year to date | +57.5% | +23.1% |
| Return, 1 year | +159.0% | +25.5% |
| P/E (TTM) | -5.7 | 11.5 |
| P/B | 60.1 | 40.6 |
| P/E percentile vs own 5y | 42nd | 36th |
| Dividend yield | – | 5.17% |
| Revenue growth (YoY, latest qtr) | +59.1% | +5.2% |
| Net profit growth (YoY) | +15.0% | +109.9% |
| Gross margin | 24.6% | 43.8% |
| Operating margin | 14.9% | 33.6% |
| Net margin | 8.1% | 23.2% |
| Return on equity | – | 1,288.4% |
| Analyst target vs. price | – | -6.2% |
| Analyst buy share | – | 0% |
| RSI (14) | 45 | 44 |
| 30-day volatility | 47.0% | 27.6% |
| Max drawdown, 1 year | -22.3% | -17.6% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | – | Sell |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
